Breast Cancer Care for patients with metastatic disease

• Conditions: C50; C76; C77; C78; C79; C80; Malignant neoplasm of breast; Malignant neoplasm of other and ill-defined sites; Secondary and unspecified malignant neoplasm of lymph nodes; Secondary malignant neoplasm of respiratory and digestive organs

• Registration Number: DRKS00013726
• Lead Sponsor: niversitätsklinikum Würzburg, Frauenklinik und Poliklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-02-06
• Study Completion: 2018-05-01
• Results First Posted: 2020-02-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 31

Inclusion Criteria

Advanced or metastatic breast cancer (ICD10: C50; C76-C80)
18 years and older
written consent of the patient or legal representative to the baseline and follow-up interviews

Exclusion Criteria

<18 years
No advanced or metastatic breast cancer

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
guideline adherence<br>Proportion of guideline compliance (S3 guideline breast cancer) Treatments on all treatments during the observation period (18 months); Questionnaire to attending physician and reports to the cancer registry